Augmented sensitivity to methotrexate by curcumin induced overexpression of folate receptor in KG-1 cells

Biochimie

Volumn 95, Issue 8, 2013, Pages 1567-1573

  Dhanasekaran, Sugapriya ^a   Biswal, Bijesh K ^a,b   Sumantran, Venil N ^a   Verma, Rama S ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Curcumin; Folate receptor; KG 1 cells; Methotrexate; Radioligand FR binding assay

Indexed keywords

CURCUMIN; CYTOTOXIC AGENT; FOLATE RECEPTOR; FOLIC ACID; MESSENGER RNA; METHOTREXATE; ANTINEOPLASTIC AGENT; FOLATE RECEPTOR 2; FOLIC ACID ANTAGONIST;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DRUG RESISTANCE, NEOPLASM; FOLATE RECEPTOR 2; FOLIC ACID ANTAGONISTS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; METHOTREXATE;

EID: 84879695470     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.04.004     Document Type: Article

References (35)

1. H. Zachariae Methotrexate side-effects Br. J. Dermatol. 36 1990 127 133
2. B.A. Chabner, and T.G. Roberts Jr. Chemotherapy and the war on cancer Nat. Rev. Cancer 5 2005 65 72
3. X. Zhao, H. Li, and R.J. Lee Targeted drug delivery via folate receptors Expert Opin. Drug Deliv. 3 2008 309 319
4. G. Jansen, G.R. Westerhof, I. Kathmann, G. Rijksen, and J.H. Schornagel Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds Cancer Chemother. Pharmacol. 28 1991 115 117
5. G.R. Westerhof, G. Jansen, N. Van Emmerik, I. Kathmann, G. Rijksen, A.L. Jackman, and J.H. Schornagel Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor mediated transport systems Cancer Res. 51 1991 5507 5513
6. G.R. Westerhof, J.H. Schornagel, I. Kathmann, A.L. Jackman, A. Rosowsky, R.A. Forsch, J.B. Hynes, F.T. Boyle, G.J. Peters, H.M. Pinedo, and G. Jansen Carrier and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity Mol. Pharmacol. 48 1995 459 471
7. W. Yan, and M. Ratnam Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal Biochemistry 34 1995 14594 14600
8. K.R. Kalli, A.L. Oberg, and G.L. Keeney Folate receptor alpha as a tumor target in epithelial ovarian cancer Gynecol. Oncol. 108 2008 619 626
9. J.F. Ross, H. Wang, and F.G. Behm Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia Cancer 85 1999 348 357
10. N. Nakashima-Matsushita, T. Tomma, S. Yu, T. Matsuda, N. Sunahara, and T. Nakamura Selective expression of folate receptor-beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis Arthritis Rheum. 42 1999 1609 1616
11. J.J. McGuire Anticancer antifolates: current status and future directions Curr. Pharm. Des. 9 2003 2593 2613
12. G.J. Peters, and G. Jansen Resistance to antimetabolites R.L. Schilsky, G.A. Milano, M.J. Ratain, Principles of Antineoplastic Drug Development and Pharmacology 1996 Marcel Dekker New York 543 585
13. M. Tsurusawa, M. Niwa, N. Katano, and T. Fujimoto Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells Cancer Res. 48 1988 4288 4293
14. K.N. Chung, Y. Saikawa, T.H. Paik, K.H. Dixon, T. Mulligan, K.H. Cowan, and P.C. Elwood Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates J. Clin. Invest. 91 1993 1289 1294
15. L.R. Espinoza, L. Zakraoui, C.G. Espinoza, F. Gutierrez, L.J. Jara, L.H. Silveira, M.L. Cuellar, and P. Martinez-Osuna Psoriatic arthritis: clinical response and side effects to methotrexate therapy J. Rheumatol. 19 1992 872 877
16. Duvoix, R. Blasius, S. Delhalle, M. Schnekenburger, F. Morceau, E. Henry, M. Dicato, and M. Diederich Chemopreventive and therapeutic effects of curcumin Cancer Lett. 223 2005 181 190
17. D. Karunagaran, R. Rashmi, and T.R. Kumar Induction of apoptosis by curcumin and its implications for cancer therapy Curr. Cancer Drug Targets 5 2005 117 129
18. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 23 2003 363 398
19. S. Shishodia, H.M. Amin, R. Lai, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive NF-kB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma Biochem. Pharmacol. 70 2005 700 713
20. Duvoix, F. Morceau, M. Schnekenburger, S. Delhalle, M.M. Galteau, M. Dicato, and M. Diederich Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat Ann. N. Y. Acad. Sci. 1010 2003 389 392
21. S. Uddin, A.R. Hussain, P.S. Manogaran, K. Al-Hussein, L.C. Platanias, M.I. Gutierrez, and K.G. Bhatia Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma Oncogene 24 2005 7022 7030
22. J. Park, V. Ayyappan, E.K. Bae, C. Lee, B.S. Kim, B.K. Kim, Y.Y. Lee, K.S. Ahn, and S.S. Yoon Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells Mol. Oncol. 4 2008 317 326
23. A. Cort, M. Timur, E. Ozdemir, E. Kucuksayan, and T. Ozben Synergistic anticancer activity of curcumin and bleomycin: an in vitro study using human malignant testicular germ cells Mol. Med. Rep. 6 2012 1481 1486
24. H. Matsue, K.G. Rothberg, A. Takashima, and B.A. Kamen Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate Proc. Natl. Acad. Sci. U S A 89 1992 6006 6009
25. B.K. Biswal, and R.S. Verma Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells J. Biochem. 146 2009 693 703
26. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidiniumthiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
27. J.S. Yuan, A. Reed, F. Chen, and C.N. Stewart Jr. Statistical analysis of real-time PCR data BMC Bioinform. 7 2006 85 10.1186/1471-2105-7-85
28. B.M. William, A. Goodrich, C. Peng, and S. Li Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia Hematology 6 2008 333 343
29. R. Motterlini, R. Foresti, R. Bassi, and C.J. Green Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress Free Rad. Biol. Med. 28 2000 1303 1312
30. C.V. Rao, A. Rivenson, B. Simi, and B.S. Reddy Chemoprevention of colon carcinogenesis by dietary curcumin a naturally occurring plant phenolic compound Cancer Res. 55 1995 259 266
31. H.P. Ammon, and M.A. Wahl Pharmacology of Curcuma longa Planta Med. 57 1991 1 7
32. J.K. Lin Molecular targets of curcumin Adv. Exp. Med. Biol. 595 2007 227 243
33. A. Chen, J. Xu, and A.C. Johnson Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1 Oncogene 25 2006 278 287
34. G. Chadalapaka, I. Jutooru, R. Burghardt, and S. Safe Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells Mol. Cancer Res. 5 2010 739 750
35. H. Wang, X. Zheng, F.G. Behm, and M. Ratnam Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia Blood 96 2000 3529 3536